ALKS vs EPAM · P/E 14, rev $1.56B vs P/E 14, rev $4.73B
Alkermes Plc (ALKS) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the ALKS and EPAM stock pages for the full models.
Not investment advice.